| 05/06/2026 5:08 AM | HOPPER PAUL (2045367) Reporting Radiopharm Theranostics (1949257) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/30/2026 8:51 PM | Laurita Aaron James (2125949) Reporting Radiopharm Theranostics (1949257) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/23/2026 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/20/2026 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/16/2026 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/08/2026 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/07/2026 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/01/2026 8:46 PM | Donnelly Noel (1922546) Reporting Radiopharm Theranostics (1949257) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 5:08 AM | Radiopharm Theranostics (1949257) Issuer Turner Ian Lawrence (2121622) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/31/2026 5:10 AM | Larkin Hester Denise (2123383) Reporting Radiopharm Theranostics (1949257) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/31/2026 5:14 AM | Canevari Riccardo (2123023) Reporting Radiopharm Theranostics (1949257) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for RADX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Radiopharm Theranostics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/27/2026 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/24/2026 5:04 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/19/2026 5:22 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/27/2026 7:01 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/24/2026 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/28/2026 6:03 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 10:31 AM | JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by Radiopharm Theranostics (1949257) Subject | Form SCHEDULE 13G/A | |
| 01/12/2026 7:05 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/08/2026 5:06 AM | Radiopharm Theranostics (1949257) Subject REGAL PARTNERS HOLDINGS PTY LTD (1569369) Filed by | Form SCHEDULE 13G | |
| 12/23/2025 2:16 PM | Radiopharm Theranostics (1949257) Filer | Form 424B3 | |
| 12/19/2025 3:17 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/17/2025 3:05 PM | Radiopharm Theranostics (1949257) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 12/16/2025 4:11 PM | Radiopharm Theranostics (1949257) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 12/15/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/10/2025 5:18 AM | Radiopharm Theranostics (1949257) Filer | Form 20-F/A | |
| 12/03/2025 8:27 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/25/2025 5:48 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/20/2025 5:18 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/19/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 5:07 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/17/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/12/2025 6:02 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/04/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/03/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/28/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/22/2025 6:18 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/20/2025 5:46 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/07/2025 5:26 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/01/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/29/2025 8:52 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
| 09/17/2025 7:00 PM | Radiopharm Theranostics (1949257) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 09/17/2025 8:23 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/15/2025 7:26 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/29/2025 7:34 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/21/2025 6:20 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/01/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/29/2025 5:57 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/28/2025 6:41 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/23/2025 5:02 AM | Radiopharm Theranostics (1949257) Subject REGAL FUNDS MANAGEMENT PTY LTD (1569369) Filed by | Form SCHEDULE 13G | |
| 07/21/2025 7:41 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/16/2025 8:34 AM | JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by Radiopharm Theranostics (1949257) Subject | Form SCHEDULE 13G/A | |
| 07/16/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/23/2025 8:53 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/12/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/10/2025 7:47 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/03/2025 8:47 PM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/02/2025 5:15 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/30/2025 8:33 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/19/2025 7:00 AM | Radiopharm Theranostics (1949257) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/12/2025 5:03 AM | Radiopharm Theranostics (1949257) Subject REGAL FUNDS MANAGEMENT PTY LTD (1569369) Filed by | Form SCHEDULE 13G | |